Skip to main content
TipRanks
Go Ultimate75% OFF

Jacobio Pharmaceuticals Group Co., Ltd. (1167) Income Statement

5 Followers

Jacobio Pharmaceuticals Group Co., Ltd. Income Statement

Last quarter (Q2 2026), Jacobio Pharmaceuticals Group Co., Ltd.'s total revenue was ¥720.78M. In Q2, Jacobio Pharmaceuticals Group Co., Ltd.'s net income was ¥592.33M. See Jacobio Pharmaceuticals Group Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 52.14M¥ 155.71M¥ 63.52M¥ 95.75M¥ 152.81M
¥ 29.35M¥ 155.71M¥ 3.20M¥ 12.63M¥ 12.83M
¥ 195.03M¥ 343.88M¥ 401.08M¥ 487.37M¥ 315.15M
Depreciation and Amortization¥ 22.81M¥ 26.45M¥ 25.08M¥ 13.79M¥ 10.79M
¥ -142.87M¥ -176.73M¥ -325.73M¥ -355.80M¥ -289.83M
¥ -165.68M¥ -188.17M¥ -397.88M¥ -394.20M¥ -319.38M
¥ 23.48M¥ 32.46M¥ 38.76M¥ 22.34M¥ 18.20M
¥ -142.20M¥ -155.71M¥ -359.12M¥ -371.86M¥ -301.19M
¥ -142.20M¥ -155.71M¥ -359.12M¥ -371.86M¥ -301.19M
Per Share Metrics
Basic EPS¥ -0.18¥ -0.20¥ -0.46¥ -0.49¥ -0.40
Diluted EPS¥ -0.18¥ -0.20¥ -0.46¥ -0.50¥ -0.40
Weighted Average Shares Outstanding774.51M774.81M772.84M751.88M747.29M
Weighted Average Shares Outstanding (Diluted)774.51M774.81M772.84M751.88M747.29M

Currency in CNY

Jacobio Pharmaceuticals Group Co., Ltd. Earnings and Revenue History

-2B-1B01B-600 %-400 %-200 %0 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin